2007Central South PharmacyRequires access

Effects of irbesartan on 24-hour heart rate variability in patients with heart failure

Youliang Huang

Open publisher page 0 citations

Abstract

Objective To explore the change of 24-hour heart rate variability(HRV) in patients with heart failure(HF) and the effects of irbesartan on the function of cardiac nerve system.Methods Altogether 130 patients with HF of different degrees were enrolled and randomly divided into 2 groups: an Irbesartan group with irbesartan treatment in 68 patients and a control group with conventional treatment in 62 patients.The 24-hour HRV was measured before and after the treatment.Results The 24-hour HRV had no difference in different time zones in patients with HF(P0.05),suggesting that circadian rhythm of HRV in HF patients disappeared.But treatment with irbesartan for 8 weeks significantly increased the 24-hour HRV and recovered daily rhythmicity in HF patients compared with the conventional treatment or before the irbesartan treatment(P0.05).Conclusion HRV may predict the state and monitor the prognosis of patients with heart failure.Irbesartan has a beneficial effect on the autonomic nervous system of heart in HF patients.

About this research paper

What this paper is about

Objective To explore the change of 24-hour heart rate variability(HRV) in patients with heart failure(HF) and the effects of irbesartan on the function of cardiac nerve system.Methods Altogether 130 patients with HF of different degrees were enrolled and randomly divided into 2 groups: an Irbesartan group with irbesartan treatment in 68 patients and a control group with conventional treatment in 62 patients.The 24-hour HRV was measured before and after the treatment.Results The 24-hour HRV had no difference in different time zones in patients with HF(P0.05),suggesting that circadian rhythm of HRV in HF patients disappeared.But treatment with irbesartan for 8 weeks significantly increased the 24-hour HRV and recovered daily rhythmicity in HF patients compared with the conventional treatment or before the irbesartan treatment(P0.05).Conclusion HRV may predict the state and monitor the prognosis of patients with heart failure.Irbesartan has a beneficial effect on the autonomic nervous system of heart in HF patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the change of 24-hour heart rate variability(HRV) in patients with heart failure(HF) and the effects of irbesartan on the function of cardiac nerve system.Methods Altogether 130 patients with HF of different degrees were enrolled and randomly divided into 2 groups: an Irbesartan group with irbesartan treatment in 68 patients and a control group with conventional treatment in 62 patients.The 24-hour HRV was measured before and after the treatment.Results The 24-hour HRV had no difference in different time zones in patients with HF(P0.05),suggesting that circadian rhythm of HRV in HF patients disappeared.But treatment with irbesartan for 8 weeks significantly increased the 24-hour HRV and recovered daily rhythmicity in HF patients compared with the conventional treatment or before the irbesartan treatment(P0.05).Conclusion HRV may predict the state and monitor the prognosis of patients with heart failure.Irbesartan has a beneficial effect on the autonomic nervous system of heart in HF patients.

Key concepts: Irbesartan, Heart rate variability, Medicine, Heart failure, Internal medicine, Cardiology, Autonomic nervous system, Heart rate

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of irbesartan on 24-hour heart rate variability in patients with heart failure — Research Paper | ScholarLens